首页> 外文会议>Conference on advancing manufacture of cell and gene therapies >OPTIMIZATION OF HEK293T SUSPENSION CULTIVATION WITH A DoE-APPROACH IN ambr®15 MICROBIOREACTOR
【24h】

OPTIMIZATION OF HEK293T SUSPENSION CULTIVATION WITH A DoE-APPROACH IN ambr®15 MICROBIOREACTOR

机译:用doe方法在ambr®15微生物反应器中优化HEK293T悬浮培养

获取原文

摘要

Cell and gene therapies present a new treatment paradigm that have the potential to address clinical needs that are unmet by current small molecule and biotherapeutic approaches. Viral vectors such as adenoviruses, adeno-associated viruses and retroviruses are effective delivery systems for genetic material used in cell and gene therapies. Especially lentiviruses are used for example for the transfer of genetic information for novel cellular immunotherapy like CAR-T cell therapy. These novel approaches promise to be a substantial part of next-generation therapies with the potential to cure devastating diseases. HEK293T cells are a workhorse cell line for lentiviral vector production for both cell and gene therapy applications. A significant challenge for the cell and gene therapy industry is to develop a HEK293T suspension cell culture processes that is well characterized and can be scaled-up for production whilst ensuring clinical and commercial success. Ambr® 15 is an automated micro-scale bioreactor system that mimics the features and process control (pH, DO, temperature, stirring rate) provided by much larger scale bioreactors, in a volume of 10 - 15 ml. Parallel processing capability and excellent reproducibility enable rapid, high throughput process improvement and optimization, including DoE studies. High-throughput tools with parallel processing, such as ambr® 15, help to address a major manufacturing bottleneck. They can be used as a scale-down model for process screening, clone selection and effective media optimization in less time with reduced reagents use and labour savings. In the study presented we used ambr® 15 for the optimization of the HEK293T culture in suspension. We identified optimal stirring speed, DO and pH value by performing a DoE approach with the use of MODDE® software for experiment planning. Viable Cell Concentration (VCC), viability and generation time have been monitored and compared to standard shake flask culture. We observed that cultivation of HEK293T cells in the ambr® 15 microbioreactor yields improved cell growth and viability as compared to standard shake flask culture. We identified that pH was the most significant factor -besides stirring speed - which has a lesser significant impact on cell health and growth. By using the MODDE® software we were able to determine an optimal set-point for improved cell growth that can be used for scaling-up studies in stirred tank reactors. This study demonstrates that the ambr® 15 micro bioreactor system in combination with the DoE MODDE® software enables a systematic investigation of critical process parameters and rapid, high throughput process improvement and optimization. The results prove that the transition from shake flask to a scalable stirred bioreactor system can be accomplished in a timely manner. A key next step is to use the identified HEK293T culture conditions to perform a DoE study with the ambr® 15 to optimize viral vector production for cell and gene therapy applications.
机译:细胞和基因疗法提出了一种新的治疗范例,有可能解决目前的小分子和生物治疗方法无法满足的临床需求。诸如腺病毒,腺伴随病毒和逆转录病毒之类的病毒载体是用于细胞和基因治疗的遗传物质的有效传递系统。特别地,慢病毒例如用于遗传信息的转移,以用于诸如CAR-T细胞疗法的新型细胞免疫疗法。这些新颖的方法有望成为下一代疗法的重要组成部分,具有治愈毁灭性疾病的潜力。 HEK293T细胞是用于细胞和基因治疗应用的慢病毒载体生产的主力细胞系。细胞和基因治疗行业面临的一项重大挑战是开发一种特征明确的HEK293T悬浮细胞培养方法,可以扩大规模生产,同时确保临床和商业成功。 Ambr®15是一种自动化的微型生物反应器系统,可模拟10-15 ml体积的大型生物反应器提供的功能和过程控制(pH,DO,温度,搅拌速率)。并行处理能力和出色的可重复性可实现包括DoE研究在内的快速,高通量的过程改进和优化。具有并行处理功能的高通量工具(例如ambr®15)有助于解决主要的制造瓶颈。它们可以用作按比例缩小的模型,用于过程筛选,克隆选择和有效的培养基优化,所需时间更少,同时减少了试剂的使用量并节省了人工。在提出的研究中,我们使用ambr®15优化了悬浮液中HEK293T的培养。通过使用MODDE®软件执行DoE方法进行实验计划,我们确定了最佳搅拌速度,DO和pH值。监测了活细胞浓度(VCC),生存力和生成时间,并将其与标准摇瓶培养进行了比较。我们观察到,与标准摇瓶培养相比,在ambr®15微型生物反应器中培养HEK293T细胞可提高细胞生长和活力。我们确定pH是最重要的因素-除了搅拌速度-对细胞健康和生长的影响较小。通过使用MODDE®软件,我们能够确定改善细胞生长的最佳设定点,该设定点可用于搅拌釜反应器中的按比例放大研究。这项研究表明,将ambr®15微型生物反应器系统与DoEMODDE®软件结合使用,可以对关键工艺参数进行系统研究,并实现快速,高通量的工艺改进和优化。结果证明从摇瓶到可扩展的搅拌生物反应器系统的过渡可以及时完成。下一步的关键步骤是使用确定的HEK293T培养条件对ambr®15进行DoE研究,以优化用于细胞和基因治疗应用的病毒载体生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号